Key result
ANS modulation emerges as an arrhythmia treatment by targeting sympathetic overactivation and vagal withdrawal.
Why the study?
Arrhythmia pathogenesis is complex, and abnormal autonomic nervous system modulation offers new perspectives and therapeutic targets for arrhythmia treatment.
Abnormal autonomic nervous system modulation is a key mechanism in arrhythmias, offering potential new therapeutic targets.
May identify ANS targets for arrhythmia therapy; leaves open validation in prospective trials before practice change.
Arrhythmia is a clinically common cardiovascular disorder characterized by high incidence and a strong association with sudden cardiac death, posing a significant threat to patient survival and quality of life. The pathogenesis of arrhythmia is complex, and abnormal autonomic nervous system (ANS) modulation, as one of the causes, offers new perspectives and therapeutic targets for arrhythmia treatment. This review discusses the mechanisms by which abnormal ANS modulation leads to arrhythmias and strategies for treating arrhythmias through ANS modulation.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) conducted a review in Arrhythmia. Autonomic nervous system modulation was evaluated. Autonomic nervous system modulation provides emerging therapeutic strategies for treating arrhythmias by targeting sympathetic overactivation, vagal withdrawal, and neuroimmune remodeling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: